
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Krystal Biotech, Inc. is a commercial-stage company focused on developing genetic medicines to address high unmet medical needs. Their mission is to develop and deliver redosable gene therapies for the treatment of severe, life-threatening, or rare diseases that have limited or no approved therapies. Krystal's first commercial product, VYJUVEK, is the pioneering redosable gene therapy designed to treat dystrophic epidermolysis bullosa. The company is advancing an integrated pipeline of genetic therapies aimed at correcting the root causes of serious and rare genetic diseases. Krystal utilizes a novel therapeutic platform based on a modified and engineered HSV-1 vector that is replication-defective and non-integrating, ensuring a safe and effective delivery of gene therapies. With two GMP facilities, Krystal is committed to the manufacturing and commercialization of transformative genetic medicines.
🕒 June 2
Director of Commercial Data & Analytics overseeing commercial analytics strategy for rare disease portfolio. Collaborating with cross-functional stakeholders to translate business strategies into measurable insights.
🕒 June 2
Regional Gene Therapy Liaison responsible for promoting Vyjuvek to specialists. Engaging with healthcare professionals in the treatment of Dystrophic Epidermolysis Bullosa at Krystal Biotech.